Citadel Advisors’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-53,700
| Closed | -$204K | – | 6061 |
|
|
2025
Q1 | $204K | Buy |
53,700
+37,587
| +233% | +$142K | ﹤0.01% | 4860 |
|
|
2024
Q4 | $87.5K | Buy |
16,113
+4,282
| +36% | +$23.3K | ﹤0.01% | 5255 |
|
|
2024
Q3 | $49.6K | Buy |
11,831
+3,418
| +41% | +$14.3K | ﹤0.01% | 5122 |
|
|
2024
Q2 | $24.8K | Sell |
8,413
-15,607
| -65% | -$46K | ﹤0.01% | 5360 |
|
|
2024
Q1 | $66.5K | Buy |
24,020
+1,305
| +6% | +$3.62K | ﹤0.01% | 5231 |
|
|
2023
Q4 | $64.5K | Buy |
22,715
+6,847
| +43% | +$19.4K | ﹤0.01% | 5031 |
|
|
2023
Q3 | $40.9K | Buy |
15,868
+7,956
| +101% | +$20.5K | ﹤0.01% | 5142 |
|
|
2023
Q2 | $34.2K | Sell |
7,912
-34,322
| -81% | -$148K | ﹤0.01% | 5115 |
|
|
2023
Q1 | $64.6K | Buy |
42,234
+3,018
| +8% | +$4.62K | ﹤0.01% | 5074 |
|
|
2022
Q4 | $62K | Buy |
39,216
+4,304
| +12% | +$6.8K | ﹤0.01% | 5206 |
|
|
2022
Q3 | $43K | Buy |
34,912
+16,900
| +94% | +$20.8K | ﹤0.01% | 5364 |
|
|
2022
Q2 | $36K | Sell |
18,012
-20,220
| -53% | -$40.4K | ﹤0.01% | 5587 |
|
|
2022
Q1 | $96K | Sell |
38,232
-27,368
| -42% | -$68.7K | ﹤0.01% | 5672 |
|
|
2021
Q4 | $245K | Buy |
65,600
+29,746
| +83% | +$111K | ﹤0.01% | 5304 |
|
|
2021
Q3 | $144K | Buy |
35,854
+10,456
| +41% | +$42K | ﹤0.01% | 5627 |
|
|
2021
Q2 | $113K | Buy |
25,398
+4,797
| +23% | +$21.3K | ﹤0.01% | 5905 |
|
|
2021
Q1 | $189K | Buy |
+20,601
| New | +$189K | ﹤0.01% | 5455 |
|